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Abstract: Introduction: The impact of endoscopic sinus surgery on bronchial asthma has been studied
by several groups. According to the latest studies, patients with chronic obstructive pulmonary
disease (COPD) seem to have frequent symptoms of chronic rhinosinusitis. Our study compares
the impact of endoscopic sinus surgery on both the upper and lower airways of patients with
bronchial asthma as well as those with COPD. Methods: This study includes 43 patients (bronchial
asthma, n = 32, COPD, n = 11) undergoing surgical treatment for chronic rhinosinusitis at the
ENT-Department, University of Homburg (Homburg, Germany). To assess the effect of sinus
surgery, the Sino-Nasal Outcome Test 20 German Adapted Version (SNOT-20 GAV) and St. George’s
Respiratory Questionnaire (SGRQ) were used both pre- and postoperatively. Results: Both SNOT-20
(p < 0.001) and SGRQ (p = 0.021) scores improved significantly after sinus surgery. The postoperative
improvement in bronchial asthma and COPD was similar in both groups, indicating no difference of
the diseases in regards to postoperative symptom improvement. There was no difference indicated
in SNOT-20 GAV or SGRQ when grouping patients by polyps, aspirin (ASS) intolerance, allergies,
eosinophilia or previous surgery. Conclusions: The treatment of chronic rhinosinusitis by sinus
surgery may help to improve the therapy outcome of patients with bronchial asthma as well as
patients with COPD.
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1. Introduction
Several research groups have studied the impact of sinus surgery on bronchial asthma and have
often noticed the term sinubronchial syndrome [1,2]. However, there is no exact definition for this term.
A current chronic rhinosinusitis guideline prefers collaboration with pneumologists [3], and a current
study by Ehnhage et al. shows the impact of sinus surgery on the symptoms and lung function
parameters in patients with bronchial asthma [4].
Hurst et al. (2006) reported investigations of chronic obstructive pulmonary diseases (COPD)
patients showing an inflammatory marker in the sputum and nasal lavage with the finding that
the entire respiratory system was affected by the inflammatory reaction [5]. Considering the
aspect of inflammatory reactions along the entire respiratory system, recent studies focused on the
incidence of rhinosinusitis in patients with chronic bronchitis and COPD. Hens et al. (2008) and
Piotrowska et al. (2010) found higher endoscopic rhinosinusitis symptom scores in patients with
COPD than in the healthy population [6,7]. In 90 patients with COPD in different disease stages,
Kelemence et al. detected clinical criteria for rhinosinusitis in 53% of the patients [8]. In a review,
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Kim and Rubin (2007) reported that 75% of all patients with COPD collectively complained of nasal
symptoms [9].
There have been multiple studies of bronchial asthma which have examined the influence and
impact of sinus surgery on pulmonary disease, however, the influence of sinus surgery on chronic
bronchitis has yet to be investigated. The aim of this study is to investigate any changes after
performing sinus surgery, in the patients’ quality of life and any symptom changes in patients with
chronic sinusitis in combination with COPD or with bronchial asthma.
2. Materials and Methods
This study includes 43 patients (22 male, 21 female) within a period ranging from January 2010
until April 2011. The median age was 50.8 years with a standard deviation of 16 years. The 43 patients
(bronchial asthma: n = 32, COPD: n = 11) underwent surgical treatment for chronic rhinosinusitis in the
ENT-Department at Saarland University Medical Center Homburg (Homburg Germany). The patients
were examined by pneumologists before being included in the study, and the pneumologists had
outlined the definition of a diagnosis of asthma or COPD. All patients gave their informed consent.
All procedures performed in studies involving human participants were in accordance with the ethical
standards of the institutional research committee and with the 1964 Helsinki declaration and its later
amendments or comparable ethical standards.
Of a possible 57 patients, 43 patients were included in the study, which resulted in a 75%
recirculation rate. There were 14 patients who were excluded due to an incomplete data source.
Patient data was anonymized. An endonasal endoscopic sinus surgery according to the concepts
of functional endoscopic sinus surgery developed by Heerman, Messerklinger, Draf, Wigand and
Stammberger [10] was performed in intubation anesthesia after informed consent. Patient file
evaluations were retrospective. A medical history and CT-Score according to Lund-Mackay was
available for every patient. To assess the effect of functional endoscopic surgery, the Sino-Nasal
Outcome Test 20 German Adapted Version (SNOT-20 GAV) and St. George’s Respiratory Questionnaire
(SGRQ) were used one week preoperatively and for a minimum of three months postoperatively.
In addition, the patients’ medical treatment for bronchial asthma and COPD was evaluated.
The SGRQ has been developed by Jones et al. [11]. The SGRQ covers the quality of life of patients
with COPD, bronchial asthma and bronchiectasis in three sub-scales (symptom, activity and strain)
and has been validated for a three month time frame [11]. The SNOT-20 is a validated questionnaire
reported by Piccirillo et al. [12], and the SNOT-20 GAV is validated by Baumann et al. [13].
Statistical analysis was tested by using a cross table and Chi-Square-Test. When the requirements
for Chi-Square-Test had not been reached, we used the Fisher-Exact-Test. The postoperative run was
tested with the Wilcoxon-Test. The Kruskal-Wallis-Test was used to compare more than two groups.
We calculated the grade of correlation coefficient according to Spearman. Level α = 0.05 was defined
as a significant level. The statistical data base was analyzed and processed under the application SPSS
“Statistical Package for the Social Sciences” (SPSS®, IBM Corporation, New York, NY, USA), Version 19
for Windows, as well as Microsoft Office Excel 2007 for Windows (Microsoft Corporation, Redmond,
WA, USA).
3. Results
There were 43 cases with at least a one-year follow-up that were analyzed after functional
endoscopic sinus surgery: There were 32 patients (74.4%) with bronchial asthma and 11 patients
(25.6%) with COPD. There were 29 patients (67.4%) who had nasal polyps, 12 patients (27.9%) who
had aspirin intolerance, and 11 patients (25.6%) who had Samter-syndrome. (Figure 1).
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Figure 1. Incidence of Aspirin-Intolerance and nasal polyp. 
Eosinophily was found in the histopathological nasal mucosa analysis of 30 patients (73.2%). 
Seasonal allergies were reported in 11 patients (25.6%), and 22 patients (51.2%) reported perennial 
allergies. 
The median CT-score according to Lund-Mackay resulted in a preoperative CT-score of 13.5 
with no difference between asthma patients and COPD patients (p = 0.277). Most patients were on 
their first or second sinus operation. A third operation was performed in six patients, a fourth 
operation was performed in two patients and a seventh operation was performed in one patient. The 
questionnaires were completed in an average postoperative rate of 4.3 ± 2.2 month. Figure 2 shows 
the medication level pre- and post- operative. The medication intake, before and after the sinus 
surgery, was insignificantly different in both groups according to the result of the Wilcoxon-Test (p = 
0.429). 
 
Figure 2. Medication level pre- and postoperative. 
Figure 1. Incidence of Aspirin-Intolerance and nasal polyp.
Eosinophily was found in the histopathological nasal mucosa analysis of 30 patients (73.2%). Seasonal
allergies were reported in 11 patients (25.6%), and 22 patients (51.2%) reported perennial allergies.
The median CT-score according to Lund-Mackay resulted in a preoperative CT-score of 13.5
with no difference between asthma patients and COPD patients (p = 0.277). Most patients were
on their first or second sinus operation. A third operation was performed in six patients, a fourth
operation was performed in two patients and a seventh operation was performed in one patient.
The questionnaires were completed in an average postoperative rate of 4.3 ± 2.2 month. Figure 2
shows the medication level pre- and post- operative. The medication intake, before and after the
sinus surgery, was insignificantly different in both groups according to the result of the Wilcoxon-Test
(p = 0.429).
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The total score of the SGRQ in all patients shows a preoperative median value of 36.3% and
a postoperative median value of 24.8% (Figure 3a). Additionally, the average improvement of
the SGRQ score, 8.3 points in asthma patients and 7.9 points in COPD patients, was statistically
significant after sinus surgery compared to the preoperative value (Figure 3b, Wilcoxon-Test: p = 0.021).
The preoperative median symptom score was 50.2% and the postoperative score was 44.6% (Figures 4
and 5). The preoperative median activity score was 42.7% and the postoperative score was 36.5%.
The preoperative median impact score was 26.9% and the postoperative score was 14.4%. The activity
score (p = 0.001) and the impact score (p = 0.003) were statistically significant, while the symptom score
was insignificant with p = 0.132 (Figure 6).
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Figure 3. (a) St. George’s Respiratory Questionnaire (SGRQ) total score; (b) SGRQ total score pre-op 
and post-op in asthma and chronic bronchitis group. pre-op: preoperative; post-op: postoperative. 
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Figure 3. (a) St. George’s Respiratory Questionnaire (SGRQ) total score; (b) SGRQ total score pre-op
and post-op in asthma and chronic bronchitis group. pre-op: preoperative; post-op: postoperative.
Green asterisk and circle are outliers.
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No statistically significant difference was found when comparing the average improvement of the
SGRQ in asthma patients and in COPD patient groups both preoperatively and postoperatively, using
the Fisher-Exact-Test (p = 0.695), (Figure 4). Dividing the groups into patients with polyps, patients
without polyps, patients with allergies, patients without allergies, patients with ASS-intolerance,
and patients without ASS-intolerance, the Fisher-Exact-Test showed no statistical significance between
the different sub-groups preoperatively nor postoperatively. All sub-groups had better results after
having sinus surgery.
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Table 1. Sino-Nasal Outcome Test 20 German Adapted Version (SNOT-20 GAV) symptom score pre-
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Thick nasal discharge 2.67 ± 1.6 1.49 ± 1.4 <0.001 
Ear fullness  1.91 ± 1.5 0.81 ± 1.2 <0.001 
Dizziness 1.16 ± 1.4 0.67 ± 1.1 0.005 
Ear pain 0.93 ± 1.1 0.51 ± 0.8 0.033 
Facial pain/pressure  2.37 ± 1.8 1.12 ± 1.2 <0.001 
Difficulty falling asleep  1.88 ± 1.7 1.26 ± 1.5 0.003 
Wake up at night  2.60 ± 1.3 1.74 ± 1.4 <0.001 
Lack of a good night’s sleep  2.81 ± 1.6 1.53 ± 1.5 <0.001 
Wake up tired  2.49 ± 1.6 1.65 ± 1.5 0.001 
Fatigue  2.70 ± 1.6 1.70 ± 1.2 <0.001 
Reduced productivity  2.47 ± 1.6 1.60 ± 1.4 0.001 
Reduced concentration  2.14 ± 1.5 1.21 ± 1.2 <0.001 
Frustrated/restless/irritable  2.14 ± 1.5 1.09 ± 1.2 <0.001 
Sad  1.65 ± 1.6 0.84 ± 1.1 0.001 
Embarrassed 1.02 ± 1.4 0.42 ± 0.8 <0.001 
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Figure 11. SNOT-20 GAV total score pre-op and post-op in asthma and chronic bronchitis group (black
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Table 1. Sino-Nasal Outcome Test 20 German Adapted Version (SNOT-20 GAV) symptom score pre-op
and post-op.
Symptom Pre-op (Ø) Post-op (Ø) p-value
Need to blow nose 2.51 ± 1.4 1.44 ± 1.2 <0.001
Sneezing 2.00 ± 1.5 0.93 ± 0.9 <0.001
Runny nose 2.21 ± 1.6 1.00 ± 1.1 <0.001
Cough 2.23 ± 1.6 1.67 ± 1.5 0.010
Postnasal discharge 2.72 ± 1.7 1.67 ± 1.4 0.001
Thick nasal discharge 2.67 ± 1.6 1.49 ± 1.4 <0.001
Ear fullness 1.91 ± 1.5 0.81 ± 1.2 <0.001
Dizziness 1.16 ± 1.4 0.67 ± 1.1 0.005
Ear pain 0.93 ± 1.1 0.51 ± 0.8 0.033
Facial pain/pressure 2.37 ± 1.8 1.12 ± 1.2 <0.001
Difficulty falling asleep 1.88 ± 1.7 1.26 ± 1.5 0.003
Wake up at night 2.60 ± 1.3 1.74 ± 1.4 <0.001
Lack of a good night’s sleep 2.81 ± 1.6 1.53 ± 1.5 <0.001
Wake up tired 2.49 ± 1.6 1.65 ± 1.5 0.001
Fatigue 2.70 ± 1.6 1.70 ± 1.2 <0.001
Reduced productivity 2.47 ± 1.6 1.60 ± 1.4 0.001
Reduced concentration 2.14 ± 1.5 1.21 ± 1.2 <0.001
Frustrated/restless/irritable 2.14 ± 1.5 1.09 ± 1.2 <0.001
Sad 1.65 ± 1.6 0.84 ± 1.1 0.001
Embarrassed 1.02 ± 1.4 0.42 ± 0.8 <0.001
4. Discussion
This study focuses on possible improvements in the quality of life of COPD patients after
sinus surgery.
The study found SGRQ improvements in patients with asthma to be 8.3 points and in patients
with COPD to be 7.9 points. 69.0% of the asthma patients and 62.5% of the COPD patients showed
postoperative improvements in a minimum of four points. In 2002, a differentiation of four points in
SGRQ was identified by Jones as being clinically relevant [14]. Therefore, this study proves for the first
time that in both groups there was a relevant improvement in the quality of life after sinus surgery.
Additionally, this study demonstrates the impact of upper airway on the lower airway
independent of the pathology in patients with COPD. The impact of sinus surgery on the lower airway
has previously been demonstrated in patients with bronchial asthma and bronchial hyperreagibility.
A significant improvement of lung function in patients with bronchial asthma was found in different
studies [4,15]. Stahl et al. [16] reported on the relation between severity of the COPD, GOLD (Global
Initiative for Chronic Obstructive Lung Disease) classification and SGRQ-score in patients with a
medial SGRQ score of 32.9%. An improvement of the peak flow in 75% was reported in Dejima et al.
Study [17]. Improvements of the subjective feeling of the patients with asthma of 70% have been noted
by Uri et al. 2002 [18].
The quality of life for patients in our study was improved after sinus surgery independent of an
additional disease pattern such as nasal polyps or ASS intolerance. Similar results have been reported
by Batra et al. (2003), which analysed 17 patients with nasal polyps and bronchial asthma as well
as nine patients with ASS-intolerance and bronchial asthma, showing the improvement of bronchial
asthma independent of ASS intolerance [19].
Comparing the results of SNOT-20 GAV and SGRQ, patients with a high preoperative SNOT-20
GAV score obviously experienced greater improvements in their postoperative quality of life.
The correlation coefficient between preoperative SGRQ and the improvement of the postoperative run,
as well as for SNOT and SGRQ, found an adequate rank level in both.
In this study, the second data acquisition was taken at a minimum of three months after sinus
surgery. Usually the oedema phase takes approximately 30 days, and after three months the healing
process is complete [20]. Baumann et al. [21] and Hopkins et al. [22] determined there was no difference
or significant outcome of SNOT-20 GAV between the three month and the one year data collection
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results and the five year results. Not all patients in this study had preoperative medication for
bronchial asthma or COPD. This was found to be a limitation when questioning medication changes
post sinus surgery. A high percentage of the study patients (22%) needed no medication therapy
pre- or postoperatively. In a European study conducted by Patridge et al. 2011, 50% of asthma patients
and 23% of COPD patients needed no medication when first questioned [23].
In this study, 28% of the patients had ASS-intolerance with a quarter of those having nasal polyps.
Based on previous studies, the prevalence of ASS-intolerance ranges from 0.6% to 2.5%, whilst the
prevalence increases to 20% in patients with asthma [3,24]. In our study group, the eosinophily in the
histopathological examination of the nasal mucosa was 72% in patients with asthma, and 64% in the
COPD patients. An allergy was known to be present in 80% of the asthma patients. Various authors
have reported the correlation of eosinophily in nasal mucosa and bronchial asthma [25,26]. Various
studies have also shown a strong correlation, up to 80%, between patients with an allergy and patients
with bronchial asthma [27,28].
In our study, the Lund-MacKay Score was 13.5 points. A score of five points was determined to
be nonpathological [29]. Patients with chronic sinusitis were found to have a score ranging from 10 to
13.4 points [30,31]. A higher score was detected [32,33] in patients with bronchial asthma
In this study, 58% of the patients had sinus surgery as a revision surgery. In previous studies,
note that the revision surgery rate ranges from 19% to 63% [34–36]. Risk factors for revision surgery
include: ASS-intolerance [37], bronchial asthma [38], allergy [39] and nasal polyps [40]. Our study
clearly demonstrates the improvement of the SNOT-20 GAV results with a preoperative median score
of 44 points and a postoperative score of 22 points. The improvement was high and statistically
significant (p < 0.001). This improvement in the SNOT-20 GAV score was independent of pulmonary
disease, ASS-intolerant, nasal polyp, allergy, CT-Score and revision surgery. Numerous studies
have confirmed the success of the operation for patients with chronic sinusitis based on a SNOT-20
score [30,31,33,41,42].
5. Conclusions
This study shows the positive impact of sinus surgery for patients with bronchial asthma as well
as for patients with COPD. The postoperative improvement was independent of pulmonary disease,
nasal polyp, allergy, eosinophily, ASS-intolerance, CT-score or revision surgery. Sinus surgery for
chronic rhinosinusitis may help to improve the therapy outcome of patients with bronchial asthma
and COPD.
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